Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ANSELL B. M., BYWATERS E. G. L. Clinical "assay" of corticotrophin; preliminary comparison of methods. Ann Rheum Dis. 1952 Sep;11(3):213–218. doi: 10.1136/ard.11.3.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DAVIES H. R., BARTER R. W., GEE A., HIRSON C. Observations on the use of butazolidin in arthritis. Br Med J. 1952 Dec 27;2(4799):1392–1394. [PMC free article] [PubMed] [Google Scholar]
- HART F. D., CLARK C. J. M. Measurement of digital swelling in rheumatoid arthritis. Lancet. 1951 Apr 7;1(6658):775–775. doi: 10.1016/s0140-6736(51)92192-7. [DOI] [PubMed] [Google Scholar]
- KELLGREN J. H., JANUS O., MOORE R., JACKSON D. S. Responsiveness to ACTH and cortisone in rheumatoid arthritis. Br Med J. 1952 May 10;1(4766):997–999. doi: 10.1136/bmj.1.4766.997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KUZELL W. C., SCHAFFARZICK R. W., BROWN B., MANKLE E. A. Phenylbutazone (butazolidin) in rheumatoid arthritis and gout. J Am Med Assoc. 1952 Jun 21;149(8):729–734. doi: 10.1001/jama.1952.02930250011004. [DOI] [PubMed] [Google Scholar]
- STEINBROCKER O., BERKOWITZ S., EHRLICH M., ELKIND M., CARP S. Phenylbutazone therapy of arthritis and other painful musculoskeletal disorders. J Am Med Assoc. 1952 Nov 15;150(11):1087–1091. doi: 10.1001/jama.1952.03680110027008. [DOI] [PubMed] [Google Scholar]
- STEPHENS C. A. L., Jr, YEOMAN E. E., HOLBROOK W. P., HILL D. F., GOODIN W. L. Benefits and toxicity of phenylbutazone (butazolidin) in rheumatoid arthritis. J Am Med Assoc. 1952 Nov 15;150(11):1084–1086. doi: 10.1001/jama.1952.03680110024007. [DOI] [PubMed] [Google Scholar]
